AARS1和AARS2:从蛋白质合成到乳糖驱动的瘤发生
Lingyue Gao1, Jihua Guo1,2, Rong Jia1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430072, China.
Biomolecules
|September 27, 2025
概括
氨基酸-tRNA合成酶 (AARSs) 最近被确定为通过乳糖化 (乳酸盐驱动的修饰) 来调控癌症的关键调节剂. 向AARS1/2或乳糖化提供了新的癌症治疗策略.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 氨基酸-tRNA合成酶 (AARS) 在蛋白质合成中具有正规的作用.
- 新出现的证据强调了AARS在癌症中的非正典功能.
- 乳酸积累和乳酸化在瘤发生过程中越来越被认可.
研究的目的:
- 审查AARS1/2在癌症中的双重作用.
- 阐明连接AARS1/2,乳和瘤性途径的机制.
- 探索针对AARS1/2和乳化的治疗策略.
主要方法:
- 关于正规和非正规的AARS函数的文献综述.
- 综合研究乳糖化作为一个后翻译性修改.
- 分析AARS1/2作为乳酸转移酶和乳酸传感器.
主要成果:
- AARS1/2作为乳酸传感器和乳酸转移酶,催化全球氨酸乳化.
- 通过AARS1/2调节的乳化与代谢重编程和扩散等癌症特征有关.
- 由AARS1/2驱动的乳糖化有助于免疫逃脱和治疗抵抗.
结论:
- AARS1/2通过乳糖化在癌症中发挥关键的,翻译独立的作用.
- 准AARS1/2或乳化通路为癌症治疗提供了一个有前途的治疗途径.
相关概念视频
Leaky Scanning
5.6K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
Initiation of Translation
38.4K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.4K
tRNA Activation
22.6K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.6K
tRNA Activation
8.3K
8.3K


